The Morning Filter cover image

5 Stocks to Buy Before They’re Not Undervalued Any More

The Morning Filter

00:00

Bristol‑Myers Squibb valuation and pipeline

Dave praises BMS's R&D pipeline, wide moat, dividend yield and reasonable multiple despite recent gains.

Play episode from 40:34
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app